JPRN-UMIN000006630尚未招募未知
Compare the add-on effects in glycemic control and durability of sitagliptin and alfa-glucosidase inhibitor uncontrolled with metformin monotherapy. - Choice trial
Saitama social insurance hospital0 个研究点目标入组 100 人开始时间: 2011年11月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who had diabetic ketoacidosis, or diabetic pre- and coma within 6 months of the study entry. 2. Patients who received surgery operation during the study. 3. Patients with pregnancy or Nursing mothers 4. Patients with renal insufficiency (serum creatinine = and > 1.5 mg/dl) 5. Patients who received insulin or GLP-1 analog therapy 6. Patients who received any oral diabetic therapy(exclusive metformin) 7. Patients who had a history of hypersensitivity reaction to sitagliptin 8. Patients whom the attending doctor estimated to be ineligible according to the medical rationale.
研究者
相似试验
招募中
4 期
Study for the effects of imeglimin on glycemic control in patients with type 2 diabetestype 2 diabetesJPRN-jRCT1011220005omoto Hiroshi70
招募中
4 期
Study for the effects of once-daily semaglutid on glycemic control in patients with type 2 diabetes (SWITCH SEMA-2 study)JPRN-jRCT1011210032omoto Hiroshi172
已完成
4 期
Study for the effects of oral semaglutide on glycemic control in patients with type 2 diabetesJPRN-UMIN000045270Hokkaido University Hospital172
进行中（未招募）
4 期
Study for the effects of semaglutid on glycemic control and quality of life in patients with type 2 diabetestype 2 diabetesD003924JPRN-jRCT1011200008omoto Hiroshi100
已完成
4 期
Study for the effects of semaglutide on glycemic control and quality of life in patients with type 2 diabetesType 2 diabetesJPRN-UMIN000042369Hokkaido University Hospital110